Screener
Crinetics Pharmaceuticals CRNX Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $47.86M.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
FAQ
- What is Crinetics Pharmaceuticals's total debt?
- Crinetics Pharmaceuticals (CRNX) reported total debt of $47.86M in Q1 2026.
- How has Crinetics Pharmaceuticals's total debt changed year-over-year?
- Crinetics Pharmaceuticals's total debt decreased by 5.8% year-over-year, from $50.82M to $47.86M.
- What is the long-term trend for Crinetics Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's total debt has grown at a 58.5% compound annual growth rate (CAGR), from $4.85M to $48.54M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Crinetics Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude